XML 86 R28.htm IDEA: XBRL DOCUMENT
v3.20.1

REVENUE (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
REVENUE |
Schedule of Company's disaggregation of revenues | The following table summarizes the Company’s disaggregation of revenues:
|  | Year ended December 31,
(U.S. dollars in thousands) |  | 2017 |  | 2018 |  | 2019
Pfizer |  | $ | 12,181 |  | $ | 5,320 |  | 6,722
Brazil |  | $ | 7,061 |  | $ | 3,658 |  | 9,144
Revenues from selling goods |  | $ | 19,242 |  | $ | 8,978 |  | 15,866
Revenues from license and R&D services |  | $ | 1,836 |  | $ | 25,262 |  | 38,827

X
- Definition The tabular disclosure for supplemental income statements. + References No definition available. + Details
Name: | plx_SupplementaryIncomeStatementInformationTableTextBlock
Namespace Prefix: | plx_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration